SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
THRIVENT FINANCIAL FOR LUTHERANS 49,942$1,3770.00%
Bank of New York Mellon Corp 455,927$12,569,9080.00%
ASSETMARK, INC 28,578$787,8950.00%
COMMERCE BANK 14,517$400,2330.00%
NEW YORK LIFE INVESTMENT MANAGEMENT LLC 9,827$270,9300.00%
NATIXIS ADVISORS, L.P. 35,678$9840.00%
State of Tennessee, Treasury Department 26,734$737,0570.00%
CANADA LIFE ASSURANCE Co 46,171$1,2730.00%
TEACHER RETIREMENT SYSTEM OF TEXAS 15,470$4270.00%
Swiss National Bank 119,700$3,300,1290.00%
Verition Fund Management LLC 9,805$270,3240.00%
Nuveen Asset Management, LLC 230,592$6,357,4210.00%
GoalVest Advisory LLC 132$3,6390.00%
Allspring Global Investments Holdings, LLC 39,583$1,091,3030.00%
Park Place Capital Corp 198$5,4590.00%
VOYA INVESTMENT MANAGEMENT LLC 46,941$1,294,1630.00%
FIRST TRUST ADVISORS LP 51,243$1,412,7690.00%
STIFEL FINANCIAL CORP 51,080$1,408,2880.00%
Russell Investments Group, Ltd. 29,896$824,2310.00%
AMERICAN CENTURY COMPANIES INC 76,533$2,110,0150.00%
External links

This page lists SUPERNUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view SUPERNUS PHARMACEUTICALS INC's shareholder history, click here.